XML 32 R15.htm IDEA: XBRL DOCUMENT v2.3.0.15
Goodwill and Other Acquisition-Related Intangible Assets
3 Months Ended
Jul. 02, 2011
Goodwill and Intangible Assets Disclosure [Abstract] 
Goodwill and Other Acquisition-Related Intangibles
Goodwill and Other Acquisition-Related Intangible Assets

The Company is required to perform an impairment analysis on its goodwill at least annually, or when events and circumstances warrant. Conditions that would trigger an impairment assessment, include, but are not limited to, a significant adverse change in legal factors or in the business climate that could affect the value of an asset or an adverse action or assessment by a regulator. The Company is considered one reporting unit. As a result, to determine whether or not goodwill may be impaired, the Company compares its book value to its market capitalization. If the trading price of the Company’s common stock as adjusted for factors such as a control premium, is below the book value per share at the date of the annual impairment test or if the average trading price of the Company’s common stock is below book value per share for a sustained period, a goodwill impairment test will be performed by comparing book value to estimated market value. If the comparison of book value to estimated market value indicates impairment, then the Company compares the implied fair value of goodwill to its carrying amount in a manner similar to a purchase price allocation for a business combination. If the carrying amount of goodwill exceeds its implied fair value, an impairment loss is recognized equal to that excess.

Unless indicators warrant testing at an earlier date, the Company performs its annual goodwill impairment test in the fourth quarter of each year. During the three and nine months ended October 1, 2011, there were no impairments recorded or impairment indicators present.

Information regarding the Company’s acquisition-related intangible assets is as follows:
 
 
 
 
October 1, 2011
 
December 31, 2010
 
Useful
Life
(Years)
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount

 
Accumulated Amortization

 
Net Carrying Amount
Goodwill
 
 
$
3,376

 
$

 
$
3,376

 
$
3,376

 
$

 
$
3,376

Amortizing intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
 
In process research and development
3-5
 
850

 
(211
)
 
639

 
600

 
(50
)
 
550

Patents, trademarks and other
2-15
 
49,653

 
(26,942
)
 
22,711

 
48,053

 
(22,547
)
 
25,506

 
 
 
50,503

 
(27,153
)
 
23,350

 
48,653

 
(22,597
)
 
26,056

Non-amortizing intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
 
In process research and development
 
 
929

 

 
929

 
1,365

 

 
1,365

Total intangible assets
 
 
51,432

 
(27,153
)
 
24,279

 
50,018

 
(22,597
)
 
27,421

Total goodwill and intangible assets
 
 
$
54,808

 
$
(27,153
)
 
$
27,655

 
$
53,394

 
$
(22,597
)
 
$
30,797



Amortization expense related to intangible assets is as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
 
October 1,
2011
 
October 2,
2010
 
October 1,
2011
 
October 2,
2010
Amortization expense
 
$
1,548

 
$
1,460

 
$
4,556

 
$
4,439




The changes in the gross carrying amount of goodwill and intangible assets are as follows:

 
 
Goodwill and Intangible Assets
 
 
Goodwill
 
In process research and development- non-amortizing
 
In process research and development- amortizing
 
Patents, trademarks and other
 
Total
Balance as of December 31, 2010
 
$
3,376

 
$
1,365

 
$
600

 
$
48,053

 
$
53,394

Additions (deductions) during the period
 

 
(436
)
 
250

 
1,600

 
1,414

Balance as of October 1, 2011
 
$
3,376

 
$
929

 
$
850

 
$
49,653

 
$
54,808




The Company’s patents, trademarks and other intangible assets are being amortized over a period of two to fifteen years. During the nine months ended October 1, 2011 a product line that was included in non-amortizing in process research and development ("IPR&D") reached technological feasibility. As a result, the Company transferred $250 to amortizing IPR&D and began amortizing this amount over a period of 3 years. During the three and nine months ended October 2, 2010, no product line reached technological feasibility.

The Company abandoned and wrote off one product line that was included in IPR&D of $186 during the three and nine months ended October 1, 2011. The Company incurred a charge of $38 for the write off of a product line during the nine months ended October 2, 2010. There were no similar charges during the three months ended October 2, 2010.

The Company purchased patents for $1,600 during the nine months ended October 1, 2011 that will be amortized over a period of eleven years. The Company did not have a similar acquisition during the nine months ended October 2, 2010.